Table 4 Summary of reported lesu use and outcomes of interest
Control group | Intervention group | |
|---|---|---|
N = 26 | N = 24 | |
Safety outcomes | ||
Adverse events (n, %) | ||
Child | 0 (0) | 1 (4.2) |
Mother | 0 (0) | 0 (0) |
Feasibility | ||
Attendance (n, %) | ||
Median number of follow-up visits (IQR) | 6 (6–6) | 6 (5–6) |
Completed both re-treatments | 25 (96.2) | 21 (87.5) |
Completed exit Interview | 26 (100.0) | 21 (87.5) |
Completed all visits | 25 (96.2) | 18 (75.0) |
Acceptability and use | ||
Daily use of lesu (n, %) | ||
Carry child on back | 26 (100.0) | 21 (100.0)* |
Blanket/swaddle for sleep | 6 (23.1) | 11 (52.4)* |
Blanket for sitting | 0 (0) | 0 (0) |
Washing (median, IQR) | ||
Reported washes per 2-week period | 4.0 (2.3–6.0) | 4.0 (3.0–6.0) |
Satisfaction (n, %) | ||
Would recommend lesu to others | 26 (100.0) | 21 (100.0)* |
Would be willing to pay more for lesu | 26 (100.0) | 21 (100.0)* |
Exploratory outcomes | ||
Illness (events per 100 person-weeks, 95% CI) | ||
Fever | 7.0 (4.2–11.1) | 8.1 (5.0–12.4) |
Care seeking for any cause | 17.0 (12.5–22.7) | 16.8 (12.1–22.7) |
Malaria treatment received | 3.0 (1.3–5.8) | 6.0 (3.4–9.9) |
Malaria testing | ||
Incident RDT positives (n) | 5 | 5 |
RDT positive prevalence (%) | 10.7 | 8.4 |
PCR Positive (n) | 2 | 0 (0) |
Change growth measuresa (median, IQR) | ||
Change in weight (kg) | 0.9 (0.5–1.3) | 0.6 (0.4–0.9) |
Change in MUAC (cm) | − 0.85 (− 1.2–0.3) | 0.2 (− 0.2–0.7) |
Change in Hb (g/dL) | 0.88 (0.5–1.3) | 0.78 (0.3–1.2) |